deltatrials
Completed PHASE2 NCT00002489

Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors

PROTOCOL FOR THE TREATMENT OF MALIGNANT NON-TESTICULAR GERM CELL TUMORS

Sponsor: Memorial Sloan Kettering Cancer Center

Conditions Extragonadal Germ Cell Tumor Ovarian Cancer
Interventions carboplatin conventional surgery cyclophosphamide dactinomycin doxorubicin hydrochloride etoposide filgrastim leucovorin calcium methotrexate vincristine sulfate
Updated 5 times since 2017 Last updated: Jun 24, 2013 Started: Oct 31, 1991 Primary completion: Jun 30, 2002 Completion: Jun 30, 2002

Listed as NCT00002489, this PHASE2 trial focuses on Extragonadal Germ Cell Tumor and Ovarian Cancer and remains completed. Sponsored by Memorial Sloan Kettering Cancer Center, it has been updated 5 times since 1991, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Oct 1991

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Memorial Sloan Kettering Cancer Center
Data source: Memorial Sloan Kettering Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • New York, United States